非阿片类止痛贴市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

非阿片类止痛贴市场按贴片类型(利多卡因贴片、双氯芬酸贴片、辣椒素贴片、酮洛芬贴片等)、分销渠道和地理位置细分

市场快照

Non-opioid Pain Patch Market CAGR
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 3.0 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

与心血管疾病、癌症和糖尿病的结合相比,疼痛对社会经济系统的影响更为深远。国际癌症研究机构 (IARC) 预测,到 2030 年,全球负担预计将增加至 2170 万新癌症病例和 1300 万癌症死亡。同样,心血管疾病 (CVD) 是全球成年人口死亡的主要原因之一。慢性疼痛以多种方式引发,例如,创伤可能包括因举重而导致的意外或背部拉伤,胰腺炎、脊柱疾病、关节炎和自身免疫性疾病等潜在疾病,或者它可能与纤维肌痛或纤维肌痛一起发生。持续性偏头痛。按照,CDC 大约 43% 的人口在某些日子遭受疼痛,大约 20% 的人口每天或大多数日子都遭受疼痛。慢性疼痛有许多危险因素。非阿片类药物贴片更可取,因为它不会像芬太尼贴片等阿片类药物贴片那样涉及成瘾风险,而且药物会在很长一段时间内释放,因此有助于在较长时间内控制疼痛并考虑作为非阿片类止痛贴市场的重要推动力。

然而,替代疗法的可用性和非阿片类药物疼痛贴片的低采用率预计将阻碍非阿片类药物疼痛贴片市场的增长。

报告范围

根据报告的范围,非阿片类药物止痛贴主要用于缓解疼痛。这些贴片通过皮肤表面释放其药物成分,阻断疼痛信号的传递。

By Patch Type
Lidocaine Patches
Diclofenac Patches
Capsaicin Patches
Ketoprofen Patches
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

利多卡因贴片部分预计将在预测年份显示出更好的增长

根据类型,市场分为利多卡因贴剂、双氯芬酸贴剂、辣椒素贴剂、​​酮洛芬贴剂等。利多卡因贴剂被认为是治疗慢性和急性疼痛最常用的贴剂。根据美国疼痛医学学会 (AAPM) 的数据,慢性疼痛影响着全世界大约 15 亿人,其患病率随着年龄的增长而增加。根据世界卫生组织的估计,2015 年至 2050 年间,世界 60 岁以上人口的比例将几乎翻一番,从 12% 增加到 22%。利多卡因贴片被推荐作为治疗老年患者神经性疼痛的一线疗法,有望促进市场增长。此外,日益增加的疾病负担,

Non-opioid Pain Patch Market 1

预计北美将主导非阿片类止痛贴市场

预计北美将保持其在该市场的主导地位。慢性疼痛是导致市场增长的主要因素之一。根据美国国立卫生研究院 (NIH) 的数据,2016 年,大约 20% 的美国成年人患有慢性疼痛,其中 8% 受到严重影响,这至少限制了患者的一项主要生活活动。此外,北美国家越来越多地面临政府当局对阿片类药物危机问题的审查,预计这反过来将有利于非阿片类药物替代品的兴起。因此,不断上升的疾病负担进一步推动了对有效和快速治疗方案的需求,预计这将在预测期内推动市场增长。

Non-opioid Pain Patch Market 2

竞争格局

非阿片类药物止痛贴市场的全球参与者是——Clarion Brands Inc.、Endo Pharmaceuticals、Hisamitsu Pharmaceutical、Sanofi、Sorrento Therapeutics (SCILEX Pharmaceuticals)、TEH SENG Pharmaceutical、Teikoku Seiyaku、Teva Pharmaceuticals 和 Veridian Healthcare。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Burden of Pain-Related Disorders

      2. 4.2.2 Rising R&D in Pain Management Treatments

      3. 4.2.3 Benefits Associated with Non-opioid Pain Patches over Conventional Medications

    3. 4.3 Market Restraints

      1. 4.3.1 Availability of Alternative Treatments

      2. 4.3.2 Low Adoption Rate of Non-opioid Pain Patch due to Unawareness

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Patch Type

      1. 5.1.1 Lidocaine Patches

      2. 5.1.2 Diclofenac Patches

      3. 5.1.3 Capsaicin Patches

      4. 5.1.4 Ketoprofen Patches

      5. 5.1.5 Others

    2. 5.2 By Distribution Channel

      1. 5.2.1 Hospital Pharmacies

      2. 5.2.2 Retail Pharmacies

      3. 5.2.3 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Clarion Brands Inc.

      2. 6.1.2 Endo Pharmaceuticals Inc.

      3. 6.1.3 Hisamitsu Pharmaceutical Co. Inc.

      4. 6.1.4 Sanofi S.A.

      5. 6.1.5 Sorrento Therapeutics (SCILEX Pharmaceuticals)

      6. 6.1.6 TEH SENG Pharmaceutical Mfg Co

      7. 6.1.7 Teikoku Seiyaku Co. Ltd.

      8. 6.1.8 Teva Pharmaceuticals Industries Ltd.

      9. 6.1.9 Veridian Healthcare

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Non-opioid Pain Patch Market market is studied from 2018 - 2026.

The Non-opioid Pain Patch Market is growing at a CAGR of 3.0% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Endo Pharmaceuticals Inc., Hisamitsu Pharmaceutical Co. Inc., Sanofi S.A., Teva Pharmaceuticals Industries Ltd., Veridian Healthcare are the major companies operating in Non-opioid Pain Patch Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!